Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 860Session 2026

Compounded Drugs

S 860 Filed

Underlined text would be added to current law. Struck-through text would be removed.

Florida Senate - 2026 SB 860 By Senator Bradley 6-00621A-26 2026860__ 1 A bill to be entitled 2 An act relating to compounded drugs; creating s. 3 499.038, F.S.; defining the term “compounded 4 medication”; prohibiting any person or entity from 5 engaging in the sale, transfer, or distribution of 6 compounded medications for weight loss unless they 7 provide specified documentation to the Department of 8 Business and Professional Regulation; providing 9 administrative penalties; authorizing the department 10 to adopt rules and conduct inspections as necessary to 11 implement specified provisions; providing an effective 12 date. 13 14 WHEREAS, the Legislature finds that the safety and 15 integrity of compounded medications are paramount for the health 16 and well-being of the residents of this state, and 17 WHEREAS, the Legislature recognizes that while the United 18 States Food and Drug Administration (FDA) sets internationally 19 recognized standards for drug approval and regulatory oversight, 20 there have been increasing attempts by bad actors to circumvent 21 these regulations, undermining public trust and patient safety, 22 and 23 WHEREAS, the Legislature further finds that foreign 24 entities, including those from countries such as China, have 25 exploited regulatory gaps to introduce inferior or contaminated 26 active pharmaceutical ingredients into the supply chain for 27 medications intended for compounding, and 28 WHEREAS, recent cases, including those involving 29 medications for weight loss, have demonstrated that high demand 30 can lead to the proliferation of the use of illicit, 31 substandard, and potentially harmful active pharmaceutical 32 ingredients that jeopardize patient health and safety, and 33 WHEREAS, while the FDA bears responsibility for enforcing 34 federal laws to protect citizens from misbranded and adulterated 35 pharmaceutical ingredients, its enforcement has proven 36 insufficient to curtail the influx of these substances into this 37 state, and despite FDA action to curb imports of active 38 pharmaceutical ingredients for weight loss medications from 39 entities that are not compliant with current good manufacturing 40 practices, patients in our state remain at risk of receiving 41 compounded medications containing such active pharmaceutical 42 ingredients, and 43 WHEREAS, the Legislature therefore finds it necessary for 44 the state to take action to protect its residents by ensuring 45 that all active pharmaceutical ingredients used in compounding 46 are sourced from reputable, registered, and inspected 47 establishments, and that only pharmaceutical-grade, safe, and 48 unadulterated ingredients are used in medications for weight 49 loss, NOW, THEREFORE, 50 51 Be It Enacted by the Legislature of the State of Florida: 52 53 Section 1. Section 499.038, Florida Statutes, is created to 54 read: 55 499.038 Regulation of medications containing certain active 56 pharmaceutical ingredients.— 57 (1) DEFINITION.—As used in this section, the term 58 “compounded medication” means a customized drug prepared by a 59 licensed pharmacist or licensed physician by combining, mixing, 60 or altering the ingredients of one or more drugs or products, 61 which drug is commonly prescribed if a commercially available 62 medication does not meet a patient’s specific health need. 63 (2) PROHIBITION.—A person or an entity may not engage in 64 the sale, transfer, or distribution of a compounded medication 65 for weight loss unless the person or entity provides 66 documentation to the department certifying all of the following: 67 (a) If a licensed pharmacist or licensed physician 68 compounds the medication pursuant to 21 U.S.C. s. 69 353a(b)(1)(A)(i)(II), that the active pharmaceutical ingredient 70 used is: 71 1. Identical to that used in the manufacture of a drug 72 approved by the United States Food and Drug Administration 73 (FDA); and 74 2. Manufactured according to the manufacturing process for 75 that ingredient as specified on the label of a drug approved by 76 the FDA. 77 (b) That the active pharmaceutical ingredient is a 78 pharmaceutical-grade product. 79 (c) That the active pharmaceutical ingredient is 80 accompanied by a valid certificate of analysis that provides 81 informational material as to the safety and effectiveness of the 82 drugs compounded using the active pharmaceutical ingredient, 83 including the identity and content of the active pharmaceutical 84 ingredient and the identity of each impurity by chemical name 85 and amount present. A certificate of analysis is not valid 86 unless it is accompanied by testing data from the original 87 manufacturing establishment demonstrating that the information 88 on the certificate of analysis is accurate. 89 (d) That the active pharmaceutical ingredient was 90 manufactured in a facility that: 91 1. Is registered with the FDA pursuant to 21 U.S.C. s. 360; 92 and 93 2. Has been inspected by the FDA as a human drug 94 establishment within the preceding 2 years, and such inspection: 95 a. Included monitoring compliance with current good 96 manufacturing practices for the relevant active pharmaceutical 97 ingredient; and 98 b. Resulted in a “Voluntary Action Indicated” or “No Action 99 Indicated” classification under the FDA’s inspection 100 classification system. 101 (e) That the person or entity conducted quality control 102 testing of the active pharmaceutical ingredient before its use 103 in a compounded drug to confirm: 104 1. The identity and content of the active pharmaceutical 105 ingredient; and 106 2. That any impurity present in the active pharmaceutical 107 ingredient has been identified, characterized, quantified, and 108 justified given the product or the product’s intended use. 109 (3) ENFORCEMENT AND PENALTIES.—A person or an entity that 110 violates this section is subject to the following penalties: 111 (a) A fine of $1,000 per dose of the illegally compounded 112 drug sold, dispensed, transferred, or distributed by the person 113 or entity; and 114 (b) Revocation of the person’s or entity’s license or 115 permit by the Board of Pharmacy or the department, as 116 applicable. 117 (4) RULEMAKING.—The department may adopt rules and conduct 118 inspections as necessary to implement this section. 119 Section 2. This act shall take effect upon becoming a law.

Official text from the Florida Legislature. Formatting has been adapted for reading on Ratifi.